Publications
Testimony from:
Lauren L. Rollins, Fellow and Editorial Director, R Street Institute
In SUPPORT of S. 1309, “AN ACT Relative to Hormonal Contraceptives”
September 10, 2019
Joint Committee on…
The United States has one of the highest unintended pregnancy rates in the world, along with some of the most restrictive contraceptive access laws. Its rates of unintended pregnancy are 16 percent…
Testimony from:
Caroline Kitchens, Director of Federal Affairs, R Street Institute
Regarding AB304, “An Act to amend 450.095 (title) and 450.095 (3); and to create 450.01 (16) (L), 450.095 (1)…
The pharmacy access model removes unnecessary regulations, provides women with more accessible healthcare options, and reduces public health expenditures. Expanding the scope of practice for…
This pharmacy access model expands birth control access in a way that saves time—pharmacists can prescribe and dispense the prescription—and sensibly increases the scope-of-practice that…
The Honorable Joseph J. Simons
Chairman, Federal Trade Commission
600 Pennsylvania Avenue, N.W.
Washington, D.C. 20530
Dear Chairman Simons:
The following comments are…
From National Journal:
Ernst and Gardner in separate interviews say they continue to advocate for the bill’s passage. Free-market advocates at the R Street Institute and other groups penned…
It’s not every day that Texas conservative Sen. Ted Cruz tweets at progressive millennial darling Rep. Alexandria Ocasio-Cortez asking to work together on something — especially when that…
Testimony from:
Courtney Joslin, Commercial Freedom Fellow, R Street Institute
Kristen Nyman, Government Affairs Specialist, R Street Institute
The Public Costs of Unintended Pregnancies
June…
From The Hill:
Courtney Joslin, a commercial freedom fellow for R Street, said progress has been slow going.
“We are working on trying to get some bipartisan support and it is really…